Ledger.Open graph →
SEC Form D · filed October 10, 2019

Variant Bio, Inc

Offering
$31.5M
Sold
$16.6M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
NEW YORK, NY
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (9)

Josh N. Wolfe · New York, NYExec · DirectorXavier Wenzel · Vancouver, British Columbia, CanadaExec · DirectorKaja Wasik · New York, NYDirectorAkhila Kosaraju · New York, NYExec · DirectorAdam Goulburn · NEW YORK, NYDirectorJohn J. Nugent · Montclair, NJExec · DirectorKaja Wasik · New York, NYDirectorAkhila Kosaraju · New York, NYExec · DirectorAdam Goulburn · NEW YORK, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗